| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 12,467,078 | 15,073,324 | 9,784,544 | | Cost of Revenue | 3,522,385 |
-
| 2,865,009 | | | Gross Profit | 8,944,693 | 15,073,324 | 6,919,535 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,300,065 | 6,683,561 | 4,020,507 | | Non Recurring |
-
|
-
|
-
| | Others | 407,749 | 1,438,621 | 983,065 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,236,879 | 6,951,141 | 1,915,963 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (789,124) | 193,955 | 135,091 | | Earnings Before Interest And Taxes | 2,241,884 | 7,249,442 | 2,011,090 | | Interest Expense | 1,589,655 | 6,467,511 | 1,200,407 | | Income Before Tax | 652,228 | 781,931 | 810,683 | | Income Tax Expense | 231,348 | (82,479) | 160,682 | | Minority Interest | 38,123 | 71,024 | 29,264 | | | | Net Income From Continuing Ops | 664,875 | 831,089 | 719,229 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 664,875 | 831,089 | 719,229 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $664,875 | $831,089 | $719,229 |
|
0.51% Nasdaq 
Income Statement
